Harbour BioMed

Harbour BioMed Wins NMPA IND Approval for HBM7004

Cambridge, Massachusetts; Rotterdam, Netherlands; and Shanghai, China, August 18, 2026 Harbour BioMed (HKEX: 02142) announced that China’s National Medical...

By cGxPwire Editor
August 19, 2026

Bio-Pharma

Harbour BioMed, Sinopharm Form Innovation R&D Consortium

Cambridge, MA, Rotterdam, Netherlands, and Shanghai, China – July 27, 2026 Harbour BioMed has entered into a strategic collaboration...

By cGxPwire Editor
July 27, 2026

.VC

Enhanced Group Secures $50 Million Financing to Accelerate Health Platform Growth

NEW YORK, June 15, 2026 Enhanced Group Inc. has announced a $50 million strategic equity financing through a private...

By cGxPwire Editor
June 16, 2026

.Tech

Harbour BioMed and BioMap Unveil AI-Powered MegaStream TechBio Platform

CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, China, June 15, 2026 Harbour BioMed and BioMap have announced a long-term strategic...

By cGxPwire Editor
June 16, 2026

Bio-Pharma

Harbour BioMed Secures Major Antibody Patent Victory Over Amgen

CAMBRIDGE, Massachusetts, ROTTERDAM, Netherlands, and SHANGHAI, China, June 14, 2026 Harbour BioMed has secured a major legal victory in...

By cGxPwire Editor
June 15, 2026

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

.Clinical

Harbour BioMed Clears Regulatory Milestone for HBM7004

CAMBRIDGE, Massachusetts; ROTTERDAM, Netherlands; SHANGHAI, China, June 10, 2026 Harbour BioMed announced that the National Medical Products Administration (NMPA)...

By cGxPwire Editor
June 10, 2026

.Clinical

Harbour BioMed Reports Strong Preclinical Results for AI-Designed Obesity Drug LET003

CAMBRIDGE, Massachusetts; ROTTERDAM, Netherlands; and SHANGHAI, China, May 18, 2026 Harbour BioMed announced promising preclinical data for LET003, its...